1. Home
  2. CTKB vs ASIX Comparison

CTKB vs ASIX Comparison

Compare CTKB & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • ASIX
  • Stock Information
  • Founded
  • CTKB 1990
  • ASIX 2016
  • Country
  • CTKB United States
  • ASIX United States
  • Employees
  • CTKB N/A
  • ASIX N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ASIX Major Chemicals
  • Sector
  • CTKB Health Care
  • ASIX Industrials
  • Exchange
  • CTKB Nasdaq
  • ASIX Nasdaq
  • Market Cap
  • CTKB 718.8M
  • ASIX 663.1M
  • IPO Year
  • CTKB 2021
  • ASIX N/A
  • Fundamental
  • Price
  • CTKB $4.00
  • ASIX $22.58
  • Analyst Decision
  • CTKB Buy
  • ASIX Strong Buy
  • Analyst Count
  • CTKB 2
  • ASIX 2
  • Target Price
  • CTKB $7.00
  • ASIX $37.50
  • AVG Volume (30 Days)
  • CTKB 957.9K
  • ASIX 166.6K
  • Earning Date
  • CTKB 05-07-2025
  • ASIX 05-02-2025
  • Dividend Yield
  • CTKB N/A
  • ASIX 2.84%
  • EPS Growth
  • CTKB N/A
  • ASIX N/A
  • EPS
  • CTKB N/A
  • ASIX 1.62
  • Revenue
  • CTKB $200,453,000.00
  • ASIX $1,517,557,000.00
  • Revenue This Year
  • CTKB $6.66
  • ASIX $8.60
  • Revenue Next Year
  • CTKB $9.54
  • ASIX $5.10
  • P/E Ratio
  • CTKB N/A
  • ASIX $13.93
  • Revenue Growth
  • CTKB 3.85
  • ASIX N/A
  • 52 Week Low
  • CTKB $3.98
  • ASIX $20.86
  • 52 Week High
  • CTKB $7.63
  • ASIX $33.00
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 32.03
  • ASIX 27.29
  • Support Level
  • CTKB $4.03
  • ASIX $22.45
  • Resistance Level
  • CTKB $4.41
  • ASIX $23.16
  • Average True Range (ATR)
  • CTKB 0.18
  • ASIX 0.68
  • MACD
  • CTKB 0.03
  • ASIX 0.03
  • Stochastic Oscillator
  • CTKB 4.21
  • ASIX 8.27

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About ASIX AdvanSix Inc.

AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.

Share on Social Networks: